BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16387122)

  • 1. The effect of in vitro recombinant factor VIIA on coagulation parameters for blood taken during liver transplantation.
    Gali B; Rettke SR; Plevak DJ; Nuttall GA; Santrach PJ; Schroeder DR
    Transplant Proc; 2005 Dec; 37(10):4367-9. PubMed ID: 16387122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation.
    Lisman T; Leebeek FW; Meijer K; Van Der Meer J; Nieuwenhuis HK; De Groot PG
    Hepatology; 2002 Mar; 35(3):616-21. PubMed ID: 11870375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of a recombinant factor Vlla in patients undergoing liver transplantation for fulminant hepatic failure.
    Jarosz K; Czupryńska M; Andrzejewska J; Wasilewicz MP; Post M; Lubikowski J; Wójcicki M; Milkiewicz P
    Transplant Proc; 2009 Oct; 41(8):3088-90. PubMed ID: 19857684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated recombinant factor VII in orthotopic liver transplantation.
    Pugliese F; Ruberto F; Summonti D; Perrella S; Cappannoli A; Tosi A; D'alio A; Bruno K; Martelli S; Celli P; Morabito V; Rossi M; Berloco PB; Pietropaoli P
    Transplant Proc; 2007; 39(6):1883-5. PubMed ID: 17692642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human coagulation factor VIIa in Jehovah's Witness patients undergoing liver transplantation.
    Jabbour N; Gagandeep S; Peilin AC; Boland B; Mateo R; Genyk Y; Selby R; Zeger G
    Am Surg; 2005 Feb; 71(2):175-9. PubMed ID: 16022020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis.
    Meijer K; Hendriks HG; De Wolf JT; Klompmaker IJ; Lisman T; Hagenaars AA; Slooff MJ; Porte RJ; van der Meer J
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):169-74. PubMed ID: 12632027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemostatic variation during perioperative period of orthotopic liver transplantation without venovenous bypass.
    Wang Y; Liu Y; Han R; Zhu Z; Zhang Y; Wang X; Wang L; Shen Z
    Thromb Res; 2008; 122(2):161-6. PubMed ID: 18048090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion triggers in orthotopic liver transplantation: a comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests.
    Coakley M; Reddy K; Mackie I; Mallett S
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):548-53. PubMed ID: 16884987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients.
    Brophy DF; Martin EJ; Nolte ME; Kuhn JG; Carr ME
    Haemophilia; 2007 Sep; 13(5):533-41. PubMed ID: 17880440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
    Rizoli SB; Boffard KD; Riou B; Warren B; Iau P; Kluger Y; Rossaint R; Tillinger M;
    Crit Care; 2006; 10(6):R178. PubMed ID: 17184516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S; Sørensen B; Poulsen LH; Ingerslev J
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in renal function in patients with severe hepatitis and liver cancer with cirrhosis during orthotopic liver transplantation].
    Li XY; Hei ZQ; Li SR; Shen N
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):386-9. PubMed ID: 17631701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid correction of prothrombin time after low-dose recombinant factor VIIA in patients undergoing orthotopic liver transplantation.
    Surudo T; Wojcicki M; Milkiewicz P; Czuprynska M; Lubikowski J; Jarosz K; Andrzejewska J; Zeair S; Sluzar T; Syczewska M; Butkiewicz J; Uminski M
    Transplant Proc; 2003 Sep; 35(6):2323-5. PubMed ID: 14529929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood coagulation monitoring during liver transplantation: Sonoclot analysis and laboratory tests].
    Bindi ML; Biancofiore GD; Consani G; Cellai F; Cecconi N; Romanelli A; Filipponi F; Mosca F; Amorese G; Vagelli A
    Minerva Anestesiol; 2001 May; 67(5):359-69. PubMed ID: 11382826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores.
    Niemann CU; Behrends M; Quan D; Eilers H; Gropper MA; Roberts JP; Hirose R
    Transfus Med; 2006 Apr; 16(2):93-100. PubMed ID: 16623915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation.
    Hendriks HG; Meijer K; de Wolf JT; Porte RJ; Klompmaker IJ; Lip H; Slooff MJ; van der Meer J
    Blood Coagul Fibrinolysis; 2002 Jun; 13(4):309-13. PubMed ID: 12032396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preemptive administration of recombinant factor VII (rVIIa) in patients transplanted due to fulminant Wilson's disease.
    Czuprynska MM; Wawrzynowicz-Syczewska M; Jureczko L; Andrzejewska J; Jarosz K; Trzebicki J; Pacholczyk M; Chmura A; Wojcicki M
    Ann Transplant; 2010; 15(3):7-10. PubMed ID: 20877260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
    Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
    Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.